Calvenza 03 EIV/EHV - 10 Dose Vial

Calvenza 03 EIV/EHV (Boehringer-Ingelheim) 10 Dose Vial  provides protection from rhinopneumonitis respiratory disease caused by EHV-4 and EHV-1 and all strains of Flu.

Order 2 or more 10 dose vials at $228.68 each, Sorry single dose not available.

Dosage: For initial vaccination, give 2 ml IM, followed by a 2nd dose IM in 3-4 weeks. Administer a third dose 3-4 weeks later either IM or intranasally. Revaccinate annually prior to anticipated exposure. It is a killed virus vaccine that provides protection against rhinopneumonitis respiratory disease caused by Rhino EHV-4 and EHV-1. Also provides immunity against equine flu types A1, A2 And cross-protects against all other equine influenza strains such as the new strains Ohio 2003, Kentucky 2/95 and Newmarket 2/93.

Please do not confuse this vaccine with Calvenza EIV Which only offers protection against Flu or Calvenza EHV which only protects EHV-1 AND EHV-4.

Benefits:

• Flexible dose administration.
• Three dose regimen conforms to AAEP recommendations.
• No reversion to virulence concern.
• Minimal vaccine site reactions.

Advantages:

• Calvenza EIV/EHV is proven safe. Calvenza EIV/EHV is proven effective by challenge.
• Dosage And Administration: Using aseptic technique inoculate horses IM with a 2 mL dose. Administer a second 2 mL dose IM in 3-4 weeks using a different injection site. Administer a third 2 mL dose in 3-4 weeks either IM or IN. Revaccinate annually.

Uses:

• For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory disease due to equine herpesvirus type 1 (EHV-1) and type 4 (EHV-4) and by equine influenza types A1 and A2.